[{"AccountsPayableCurrent_0_Q2_USD":60002000.0,"OperatingIncomeLoss_2_Q2_USD":-407564000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":49787000.0,"OtherAssets_0_Q2_USD":110927000.0,"OtherAssetsCurrent_0_Q2_USD":18907000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-129000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-34000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":17501000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-2093000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-3051000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-4751000.0,"OtherPrepaidExpenseCurrent_0_Q2_USD":2518000.0,"PaidInKindInterest_2_Q2_USD":5649000.0,"PaymentsForTenantImprovements_2_Q2_USD":0.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":3750000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1657000.0,"PrepaidExpenseCurrent_0_Q2_USD":48871000.0,"OperatingIncomeLoss_1_Q2_USD":-171891000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":308743000.0,"OperatingExpenses_2_Q2_USD":514119000.0,"NonoperatingIncomeExpense_2_Q2_USD":-60749000.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_2_Q2_USD":4243000.0,"Liabilities_0_Q2_USD":1242489000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":845893000.0,"LiabilitiesCurrent_0_Q2_USD":399132000.0,"LongTermDebt_0_Q2_USD":274138000.0,"LongTermDebtCurrent_0_Q2_USD":0.0,"LongTermDebtNoncurrent_0_Q2_USD":274138000.0,"MarketableSecuritiesCurrent_0_Q2_USD":59840000.0,"MinorityInterest_0_Q2_USD":-2719000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":446187000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":160636000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-432716000.0,"NetIncomeLoss_1_Q2_USD":-210619000.0,"NetIncomeLoss_2_Q2_USD":-475587000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-540000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-900000.0,"NonoperatingIncomeExpense_1_Q2_USD":-34918000.0,"OperatingExpenses_1_Q2_USD":247485000.0,"InvestmentIncomeNet_2_Q2_USD":104000.0,"ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_2_Q2_USD":35170000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":1090000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1252530.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":525563000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":8573800.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":35.78,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":525563000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":8573800.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":35.78,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":35.05,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":55.98,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":82.53,"SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent_0_Q2_USD":62500000.0,"SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_0_Q2_USD":133091000.0,"StockholdersEquity_0_Q2_USD":-453877000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":-456596000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":153847.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":65112179.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":63584932.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":70790.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":8643000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":25.91,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":384734000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":162293000.0,"ProfitLoss_1_Q2_USD":-211159000.0,"ProfitLoss_2_Q2_USD":-476487000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":10885000.0,"RedeemableNoncontrollingInterestEquityCarryingAmount_0_Q2_USD":60000000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":1195000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":77428000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":184539000.0,"RestrictedCashCurrent_0_Q2_USD":1132000.0,"RestrictedCashNoncurrent_0_Q2_USD":750000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-2214756000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":92933000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":136756000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":170057000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":329580000.0,"ShareBasedCompensation_1_Q2_USD":25586000.0,"ShareBasedCompensation_2_Q2_USD":74312000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":5406077.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":65112179.0,"InvestmentIncomeNet_1_Q2_USD":65000.0,"InvestmentIncomeInvestmentExpense_1_Q2_USD":24000.0,"CommonStockSharesIssued_0_Q2_shares":65240458.0,"CommonStockSharesOutstanding_0_Q2_shares":65240458.0,"CommonStockValue_0_Q2_USD":1618194000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-210748000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-475621000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":-540000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":-900000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-211288000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-476521000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":17339000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":30201000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":285127000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q2_USD":10989000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_0_Q2_USD":59809000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q2_investment":0.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":31387000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q2_investment":9.0,"CommonStockNoParValue_0_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":173918000.0,"AccountsReceivableNetCurrent_0_Q2_USD":168637000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":276630000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":27273000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":280000.0,"AdditionalPaidInCapital_0_Q2_USD":142405000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":25586000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":9860022.0,"Assets_0_Q2_USD":845893000.0,"AssetsCurrent_0_Q2_USD":666580000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":35000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":4000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":59809000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_0_Q2_USD":59809000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q2_USD":59840000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":59840000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":306267000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":308149000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InvestmentIncomeInvestmentExpense_2_Q2_USD":76000.0,"DebtSecuritiesRealizedGainLoss_1_Q2_USD":0.0,"DepreciationDepletionAndAmortization_2_Q2_USD":11278000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":7051000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":79832000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-28138000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-28710000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":57501000.0,"InterestExpenseDebt_1_Q2_USD":8042000.0,"InterestExpenseDebt_2_Q2_USD":15985000.0,"InterestExpenseDebtExcludingAmortization_2_Q2_USD":15985000.0,"InterestExpenseOther_1_Q2_USD":7836000.0,"InterestExpenseOther_2_Q2_USD":15567000.0,"InventoryFinishedGoods_0_Q2_USD":3462000.0,"InventoryNet_0_Q2_USD":64058000.0,"InventoryNoncurrent_0_Q2_USD":33728000.0,"InventoryRawMaterials_0_Q2_USD":0.0,"InventoryWorkInProcess_0_Q2_USD":94324000.0,"InvestmentIncomeInterestAndDividend_1_Q2_USD":89000.0,"InvestmentIncomeInterestAndDividend_2_Q2_USD":161000.0,"IncreaseDecreaseInInventories_2_Q2_USD":19046000.0,"DebtSecuritiesRealizedGainLoss_2_Q2_USD":19000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":63868000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":5085000.0,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":15890000.0,"EarningsPerShareBasic_1_Q2_USD":-3.23,"EarningsPerShareBasic_2_Q2_USD":-7.48,"EarningsPerShareDiluted_1_Q2_USD":-3.23,"EarningsPerShareDiluted_2_Q2_USD":-7.48,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-189000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":26964000.0,"EquityMethodInvestments_0_Q2_USD":0.0,"FinanceLeasePrincipalPayments_2_Q2_USD":2514000.0,"GrossProfit_1_Q2_USD":75594000.0,"GrossProfit_2_Q2_USD":106555000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-206809000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-468313000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":0.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":5261000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":4350000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":8174000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":48526000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":63584932.0,"Ticker":"BHVN","CIK":"1689813","name":"BIOHAVEN PHARMACEUTICAL HOLDING CO LTD.","OfficialName":"Biohaven Pharmaceutical Holding Company Ltd. Common Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7425158774.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210809"}]